Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are investigating whether applying tranexamic acid TXA directly onto the surgical wound can influence the occurrence of complications after plastic surgery. The study focuses on complications such as re-bleeding needing intervention, wound infections, wound rupture, seroma formation, or blood clots. This is a phase 4 prevention trial involving patients undergoing plastic surgery procedures where TXA might be used to reduce bleeding. Participants will receive a single local application of the study drug at the end of surgery. The study drug is provided in identical ampoules containing either tranexamic acid or a saline placebo, and neither the participants nor the study staff will know which they receive. The drug will be diluted and applied according to standard surgical practices. The trial compares the effects of TXA versus placebo on postoperative complications. During the 30 days following surgery, researchers will collect data on any serious complications through medical record review, electronic self-report forms sent to patients, and follow-up phone calls. The primary outcome is postoperative re-bleeding within 10 days, with secondary outcomes including infections, wound rupture, seroma, thromboembolic events, and other adverse effects within 30 days. Safety and scientific integrity are overseen by an independent data monitoring committee, and all information is stored securely in a web-based system.